Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release shortage
Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release is currently listed in shortage by the FDA. The FDA lists 1 affected product. This page was last refreshed from FDA data on Oct 3, 2026.
Viatris is permanently stopping its generic doxylamine-pyridoxine delayed-release tablets (10 mg). The same 10 mg delayed-release tablet is still listed by other makers, including the brand Diclegis (doxylamine succinate and pyridoxine hydrochloride); Bonjesta, a higher-dose extended-release version, is also available from Duchesnay USA.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Jan 12, 2026Currently in shortage1 of 1 product affected.
-
Jan 12, 2026First reported to the FDA1 product first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Mylan Pharmaceuticals Inc., a Viatris Company 📞 800-796-9526 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Doxylamine Succinate and Pyridoxine Hydrochloride, Tablet, Delayed Release, 10 mg; 10 mg (NDC 0378-4615-01) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
These rows are manufacturer reports to the FDA for Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release? options further down this page.
Why is Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release in shortage?
Mylan Pharmaceuticals (a Viatris company) has let the FDA know that they made a business decision to permanently stop making their version of doxylamine succinate and pyridoxine hydrochloride 10 mg / 10 mg delayed-release tablets (NDC 0378-4615-01). No specific reason beyond that business decision was shared publicly.
It's worth knowing that this report only covers Mylan's product — it doesn't mean every version of this medication is going away. Other manufacturers may still produce it and are listed separately. But as far as Mylan's tablets go, they will not be coming back.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release?
Doxylamine succinate and pyridoxine (the delayed-release combination tablet, often used for nausea in pregnancy) is currently on the FDA shortage list. Please know that this affects one manufacturer's product — it does not mean the medicine has disappeared from every maker.
The strength involved is the 10 mg / 10 mg delayed-release tablet made by Mylan (a Viatris company). This specific product has no available source right now. The company reports this is because of a business decision to discontinue manufacturing it, which means this particular version is being permanently stopped rather than temporarily out of stock.
Because this is a discontinuation, the most important step is to plan ahead calmly with your care team. Here is what I suggest:
- Do not stop, skip, or change your dose on your own.
- The same medicine (doxylamine 10 mg / pyridoxine 10 mg, delayed-release) is still made by other companies, including Actavis, Par Health, Bionpharma, Analog Pharma, and Bryant Ranch. Ask your pharmacy whether they can order one of these — though it may not be in local stock today.
- Talk with your prescriber or pharmacist about the best path forward for you.
Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls. This is general, national information and may not match your local pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Doxylamine Succinate And Pyridoxine Hydrochloride | DOXYLAMINE SUCCINATE 10 mg/1; PYRIDOXINE HYDROCHLORIDE 10 mg/1 | Tablet, Delayed Release · Oral | Actavis Pharma, Inc. | 00591-2132-01 |
| Doxylamine Succinate And Pyridoxine Hydrochloride | DOXYLAMINE SUCCINATE 10 mg/1; PYRIDOXINE HYDROCHLORIDE 10 mg/1 | Tablet, Delayed Release · Oral | Par Health USA, LLC | 49884-0186-01 |
| Diclegis | DOXYLAMINE SUCCINATE 10 mg/1; PYRIDOXINE HYDROCHLORIDE 10 mg/1 | Tablet, Delayed Release · Oral | Duchesnay USA, Inc. | 55494-0100-10 |
| Bonjesta | DOXYLAMINE SUCCINATE 20 mg/1; PYRIDOXINE HYDROCHLORIDE 20 mg/1 | Tablet, Extended Release · Oral | Duchesnay USA, Inc. | 55494-0120-10 |
| Doxylamine Succinate And Pyridoxine Hydrochloride | DOXYLAMINE SUCCINATE 10 mg/1; PYRIDOXINE HYDROCHLORIDE 10 mg/1 | Tablet, Delayed Release · Oral | Bryant Ranch Prepack | 63629-2184-01 |
| Doxylamine Succinate And Pyridoxine Hydrochloride | DOXYLAMINE SUCCINATE 10 mg/1; PYRIDOXINE HYDROCHLORIDE 10 mg/1 | Tablet, Delayed Release · Oral | Bionpharma Inc., | 69452-0206-20 |
| Doxylamine Succinate And Pyridoxine Hydrochloride | DOXYLAMINE SUCCINATE 10 mg/1; PYRIDOXINE HYDROCHLORIDE 10 mg/1 | Tablet, Delayed Release · Oral | Analog Pharma | 70505-0100-10 |
Therapeutic equivalents & pricing 8 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Doxylamine succinate and pyridoxine hydrochloride 10 mg/1; 10 mg | Actavis | 100 tablets | $1.092 | AB | Availability likely |
| Doxylamine Succinate and Pyridoxine Hydrochloride 10 mg/1; 10 mg | Par | 100 tablets | $1.092 | AB | Availability likely |
| Doxylamine succinate and Pyridoxine hydrochloride 10 mg/1; 10 mg | Bionpharma | 100 tablets | $1.092 | AB | Availability likely |
| Doxylamine succinate and pyridoxine hydrochloride 10 mg/1; 10 mg | Analog | 100 tablets | $1.092 | AB | Availability likely |
| Doxylamine Succinate and Pyridoxine Hydrochloride 10; 10 mg/1; mg | Mylan | 100 tablets | $1.263 | — | Discontinued |
| Diclegis 10 mg/1; 10 mg | Duchesnay | 100 tablets | $1.676 | AB | Availability likely |
| Doxylamine Succinate and Pyridoxine Hydrochloride 10 mg/1; 10 mg | Bryant | 100 tablets | — | AB | FDA listed |
| Doxylamine Succinate and Pyridoxine Hydrochloride 10 mg/1; 10 mg | Bryant | 100 tablets | — | AB | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release — that fall in the same broad treatment class (antiemetic/antivertigo agents) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other other shortages
Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release shortage FAQs
Is Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release in shortage?
Which products are affected?
When will Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release be available again?
Can I still get Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release somewhere?
What should I do if I take Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release?
Still have a question about the Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release shortage?
Ask a pharmacist about this shortage →View Doxylamine Succinate And Pyridoxine Hyd... on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.